计算溶液所需的质量、体积或浓度。
提供 ≥99% 纯度,适用于对基线干扰要求严格的色谱和分析工作流程。
干燥,-80℃储存。特低温运输 。请查阅批次 COA 获取详细规格。
SDS、COA、产品数据表及规格说明书均可下载。可通过批号查询获取批次 COA。
在色谱分析、有机合成和交叉偶联反应领域已被 0 篇同行评审文献引用。
Angiopeptin TFA, a cyclic octapeptide analogue of somatostatin, is a weak sst 2 /sst 5 receptor partial agonist with IC 50 values of 0.26 nM and 6.92 nM, respectively. Angiopeptin TFA is a potent inhibitor of growth hormone release and insulin-like growth factor-1 (IGF-1) production. Angiopeptin TFA inhibits adenylate cyclase or stimulates extracellular acidification. Angiopeptin TFA has the potential for coronary atherosclerosis research
In Vitro
Angiopeptin (0.1 nM- 10 μM; for 1 h) TFA acts as a partial agonist (pEC 50 =6.57) with a maximum response of 423% at 3 μM on the release of tritium on CHO hsst 2 cells. MCE has not independently confirmed the accuracy of these methods. They are for reference only.
In Vivo
Angiopeptin (20 and 50μg/kg; i.h.) TFA significantly inhibits neointimal formation . Angiopeptin (20 μg/kg; per day) TFA significantly inhibits coronary artery myointimal proliferation in cardiac allografts by appmximalely 50% . MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Form:Solid
IC50& Target:IC50: 0.26 nM (sst2) and 6.92 nM (sst5)